China Pharma Hldgs Inc.
13F holders, Q1 2025 (March 31)At the end of Q1 2025, 6 institutions reported holding China Pharma Hldgs Inc. in their 13F filings, up 1 from Q4 2024. 3 opened new positions and 2 sold out. The largest holders were UBS Group AG ($27K), XTX Topco Ltd ($22K) and Citadel Advisors ($14K). 2 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- China Pharma Hldgs Inc.
- CUSIP
- 16941T302
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $32K |
| Exits | 2 | $1K |
All 13F filers, Q4 2024 → Q1 2025: 213,900 shares bought and 49,857 shares sold, net +164,043 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| UBS Group AG | 0.00% | Add +231.6% | 104,476 | $27K |
| XTX Topco Ltd | 0.00% | Add +24.8% | 83,790 | $22K |
| Citadel Advisors | 0.00% | New | 53,056 | $14K |
| Renaissance Technologies | 0.00% | New | 46,100 | $12K |
| Two Sigma Securities, LLC | 0.00% | Reduce -63.7% | 25,337 | $7K |
| HRT Financial LP | 0.00% | New | 25,111 | $6K |
"% of holder's portfolio" is CHINA PHARMA HLDGS INC's weight in each manager's 13F, not the share of China Pharma Hldgs Inc. the manager owns.